FDA cleared Coreline Soft's AVIEW Aorta Metrics on October 16, the company's 13th US 510(k). The software segments the aorta from a chest CT and measures diameters across anatomical regions. It also classifies aortic zones and produces curved planar reformation, cross sectional and 3D views with an analysis report.
The clearance extends a portfolio built on reading one chest CT several ways, alongside the company's lung nodule and coronary calcium tools. Coreline says the next move is PACS-integrated automation with INFINITT North America rather than standalone hospital installs. Whether a measurement tool gets used in a radiology department depends more on that integration work than on the clearance that precedes it.
Questions & Answers
What is Coreline Soft AVIEW Aorta Metrics?
AVIEW Aorta Metrics is AI software from Coreline Soft that automatically segments the aorta from chest CT images, measures diameters across anatomical regions, classifies aortic zones and generates analysis reports. FDA cleared it on October 16, 2026.
How many FDA clearances does Coreline Soft have?
The AVIEW Aorta Metrics clearance on October 16, 2026 was Coreline Soft's 13th FDA 510(k) clearance.
What else is in the Coreline Soft AVIEW platform?
Coreline Soft's AVIEW platform analyzes several diseases from a single chest CT, including lung nodule tools and AVIEW CAC for coronary artery calcium. The company is also building PACS-integrated automation with INFINITT North America.